| Date Filed | Type | Description |
| 06/16/2023 |
4
| Hitchcock Michael J.M. (Director) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 06/16/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 06/16/2023 |
4
| Faust Elizabeth (Director) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 06/16/2023 |
4
| AGUIAR ERIC (Director) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 06/16/2023 |
4
| Ray Sumita (Director) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 06/02/2023 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 4,273 shares
@ $3.7825, valued at
$16.2k
|
|
| 06/02/2023 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Sold 75,000 shares
@ $33.81, valued at
$2.5M
Sold 50,000 shares
@ $34.5633, valued at
$1.7M
|
|
| 05/17/2023 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Sold 25,000 shares
@ $33.84, valued at
$846k
|
|
| 05/10/2023 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Sold 100,000 shares
@ $33.9931, valued at
$3.4M
Sold 150,000 shares
@ $34.5048, valued at
$5.2M
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 400,000 shares
@ $30, valued at
$12M
|
|
| 02/10/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/10/2023 |
4
| Erdtmann Rainer M (President and COO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 118,000 options to buy
@ $7.05, valued at
$831.9k
|
|
| 01/10/2023 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 126,300 options to buy
@ $7.05, valued at
$890.4k
|
|
| 01/10/2023 |
4
| Butler Thomas Andrew (CEO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 354,350 options to buy
@ $7.05, valued at
$2.5M
|
|
| 12/02/2022 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 2,518 shares
@ $3.7825, valued at
$9.5k
|
|
| 11/16/2022 |
4
| Hitchcock Michael J.M. (Director) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 5,000 shares
@ $7.93, valued at
$39.7k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 10,000 shares
@ $8.6767, valued at
$86.8k
|
|
| 12/07/2021 |
4
| Butler Thomas Andrew (CEO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 305,400 options to buy
@ $9.8, valued at
$3M
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 34,658 shares
@ $10.96, valued at
$379.9k
|
|
|